nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

12.02.2018 | Supraventrikuläre Tachykardien | Übersichten

Management von inadäquaten Schocks/T-Wellen-Oversensing bei S-ICD®-Patienten

verfasst von: Dr. med. Robert Larbig, Dr. med. Markus Bettin, Dr. med. Lukas J. Motloch, Dr. med. Alicia Fischer, Dr. med. Niklas Bode, PD Dr. med. Gerrit Frommeyer, Dr. med. Florian Reinke, Dr. med. Andreas Loeher, Prof. Dr. med. Lars Eckardt, PD Dr. med. Julia Köbe

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Inadäquate Schockabgaben sind eine gefürchtete Komplikation bei Patienten nach Implantation eines Kardioverter-Defibrillators, welche die Lebensqualität der betroffenen Patienten sehr stark beeinträchtigt. Die Ursachen von inadäquaten Schockabgaben beim subkutanen ICD (S-ICD®, Boston Scientific, Marlborough, MA, USA) sind vielfältig. Diese Übersichtsarbeit fasst die aktuelle Literatur zu diesem Thema zusammen und zeigt mögliche Behandlungsstrategien.

Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB et al (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S‑ICD Registry. Eur Heart J 35:1657–1665CrossRefPubMedPubMedCentral

Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P et al (2017) Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol 70:830–841CrossRefPubMed

Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al (2015) ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015(36):2793–2867CrossRef

Kobe J, Hucklenbroich K, Geisendorfer N, Bettin M, Frommeyer G, Reinke F et al (2016) Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol 106(5):317–321. https://doi.org/10.1007/s00392-016-1055-0 CrossRefPubMed

Kooiman KM, Knops RE, Nordkamp OL, Wilde AA, de Groot JR (2014) Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T‑wave oversensing can be prevented: implications for management. Heart Rhythm 11:426–434CrossRefPubMed

Nordkamp OLR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ et al (2012) The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 60:1933–1939CrossRef

Boveda S, Lenarczyk R, Haugaa K, Fumagalli S, Madrid AH, Defaye P et al (2016) Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey. Europace 18:1434–1439CrossRefPubMed

Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Nordkamp OLR, Schalij MJ et al (2016) Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol 68:2047–2055CrossRefPubMed

Sousa MJ, Betts T (2017) Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block. J Arrhythm 33:73–75CrossRefPubMed

10.

Lambiase PD, Gold MR, Hood M, Boersma L, Theuns DA, Burke MC et al (2016) Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts. heart Rhythm 13:1066–1074CrossRefPubMed

11.

Frommeyer G, Dechering DG, Zumhagen S, Loher A, Kobe J, Eckardt L et al (2016) Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience. Clin Res Cardiol 105:89–93CrossRefPubMed

12.

Batul SA, Yang F, Wats K, Shrestha S, Greenberg YJ (2017) Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R‑wave amplitude variation: another challenge in device management. HeartRhythm Case Rep 3:78–82CrossRefPubMed

13.

Maurizi N, Olivotto I, Nordkamp OLR, Baldini K, Fumagalli C, Brouwer TF et al (2016) Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Heart Rhythm 13(63):457CrossRefPubMed

14.

Srinivasan NT, Patel KH, Qamar K, Taylor A, Baca M, Providencia R et al (2017) Disease severity and exercise testing reduce subcutaneous implantable cardioverter-defibrillator left sternal ECG screening success in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 10(4):e4801. https://doi.org/10.1161/CIRCEP.117.004801 CrossRefPubMed

15.

Maurizi N, Tanini I, Olivotto I, Amendola E, Limongelli G, Losi MA et al (2017) Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy. Int J Cardiol 231:115–119CrossRefPubMed

16.

Morani G, Bolzan B, Tomasi L, Tomei R, Vassanelli C (2017) Pitfalls in electrogram interpretation: subcutaneous cardioverter defibrillator malfunction in brugada syndrome. Pacing Clin Electrophysiol 40(10):1180–1183. https://doi.org/10.1111/pace.13091 CrossRefPubMed

17.

Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H et al (2017) Impact of electrocardiogram screening during drug challenge test for the prediction of T‑wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome. Heart Vessels 32(10):1277–1283. https://doi.org/10.1007/s00380-017-0994-3 CrossRefPubMed

18.

El-Chami MF, Harbieh B, Levy M, Leon AR, Merchant FM (2016) Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD. J Arrhythm 32:181–185CrossRefPubMedPubMedCentral

19.

Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA et al (2012) Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 23:359–366CrossRefPubMed

20.

Bettin M, Larbig R, Rath B, Fischer A, Frommeyer G, Reinke F, Koebe J, Eckardt L (2017) Long-term experience with the subcutaneous ICD in teenagers and young adults. JACC Clin Electrophysiol. https://doi.org/10.1016/j.jacep.2017.08.017

21.

Frommeyer G, Dechering DG, Kochhauser S, Bettin M, Koebe J, Eckardt L et al (2016) Long-time „real-life“ performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation. J Interv Card Electrophysiol 47:185–188CrossRefPubMed

22.

Nordkamp OLR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB et al (2015) Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. int J Cardiol 195:126–133CrossRef

23.

Afzal MR, Evenson C, Badin A, Patel D, Godara H, Essandoh M et al (2017) Role of exercise electrocardiogram to screen for T‑wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 14(10):1436–1439. https://doi.org/10.1016/j.hrthm.2017.06.022 CrossRefPubMed

24.

Cohen MI, Shaffer J, Pedersen S, Sims JJ, Papez A (2011) Limited utility of exercise-stress testing to prevent T‑wave oversensing in pediatric internal cardioverter defibrillator recipients. Pacing Clin Electrophysiol 34:436–442CrossRefPubMed

25.

Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V et al (2015) A new algorithm to reduce inappropriate therapy in the S‑ICD system. J Cardiovasc Electrophysiol 26:417–423CrossRefPubMed

26.

Gold MR, Weiss R, Theuns DA, Smith W, Leon A, Knight BP et al (2014) Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. heart Rhythm 11:1352–1358CrossRefPubMed

27.

Clementy N, Challal F, Marijon E, Boveda S, Defaye P, Leclercq C et al (2017) Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. Heart Rhythm 14:211–217CrossRefPubMed

28.

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J et al (2016) 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace 18:159–183CrossRefPubMed

29.

Sovari AA, Ehdaie A, Liu Q, Wang X, Swerdlow C, Shehata M (2017) Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing. HeartRhythm Case Rep 3:133–136CrossRefPubMed

30.

Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283CrossRefPubMed

Titel: Management von inadäquaten Schocks/T-Wellen-Oversensing bei S-ICD®-Patienten
verfasst von: Dr. med. Robert Larbig
Dr. med. Markus Bettin
Dr. med. Lukas J. Motloch
Dr. med. Alicia Fischer
Dr. med. Niklas Bode
PD Dr. med. Gerrit Frommeyer
Dr. med. Florian Reinke
Dr. med. Andreas Loeher
Prof. Dr. med. Lars Eckardt
PD Dr. med. Julia Köbe
Publikationsdatum: 12.02.2018
Verlag: Springer Medizin
Schlagwörter: Supraventrikuläre Tachykardien
EKG
Schock
Plötzlicher Herztod
EKG
Ergometrie
Ergometrie
Schock
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 1/2018
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-018-0555-1

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Management von inadäquaten Schocks/T-Wellen-Oversensing bei S-ICD®-Patienten

Zusammenfassung

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Cardiac fibroblasts

Correction to: Atrial thrombogenesis in atrial fibrillation. Results from atrial fibrillation models and AF‑patients

Ion channels as part of macromolecular multiprotein complexes

The 125th anniversary of the His bundle discovery

The power of optogenetics

Jahresbericht 2015 des Deutschen Herzschrittmacher- und Defibrillatorregisters, Teil 2 – Implantierbare Kardioverter-Defibrillatoren (ICD)

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie